| Name |
Respimucil 600 mg šumeće tablete |
| Former Name |
Acetilcistein Zambon 600 mg šumeće tablete |
| Marketing Authorisation Number |
HR-H-839372361 |
| Active Substance |
acetilcistein |
| Composition |
jedna šumeća tableta sadrži 600 mg acetilcisteina |
| Pharmaceutical Form |
Šumeća tableta |
| Manufacturer |
Zambon S.p.A., Vicenza, Italija |
| Marketing Authorisation Holder |
Zambon S.p.A., Via Lillo del Duca, 10, Bresso (Milano), Italija |
| Marketing Authorisation Date |
15.09.2023 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/23-02/119 |
| Registration Number |
381-12-01/70-23-05 |
| Prescription |
Medicinal product not subject to medical prescription |
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
allowed |
| ATC Code |
R05CB01 |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
| Summary of risk management plan |
download |
